Pancreatic Adenocarcinoma Clinical Trials in Newport Beach, California
4 studies are recruiting for pancreatic adenocarcinoma in Newport Beach, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for rec…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Hoag Memorial Hospital Presbyterian, Newport Beach, California
- Locations
- 57 in total
- Run by
- Guardant Health, Inc.
-
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Phase I Study of NT-175, an autologous T cell therapy product genetically engineered to express an HLA-A*02:01-restricted T cell receptor (TCR), targeting TP53 R175H mutant malignancies
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Research Site, Newport Beach, California
- Locations
- 23 in total
- Run by
- AstraZeneca
-
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab, docetaxel, or Pumitamig in participants with advanced solid tumors. This study is a first-in-human (FIH) study of BMS-986340 in participants with …
- Stage
- Phase 1
- Ages
- 18 and older
- Site
- Hoag Memorial Hospital Presbyterian, Newport Beach, California
- Locations
- 47 in total
- Run by
- Bristol-Myers Squibb
-
Pancreatic Cancer Detection Consortium
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Hoag Center, Newport Beach, California
- Locations
- 11 in total
- Run by
- City of Hope Medical Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.